Democrats on the House Oversight Committee have kicked off an investigation into prescription drug prices, sending letters yesterday to 12 drug companies seeking information about the pricing of almost 20 specific products.
What's happening: The list includes some of the best-selling drugs in the world — Humira, Embrel and Revlimid — as well as insulin, whose staggering price hikes have stoked particular rage.